Literature DB >> 3590098

Carriers of hepatitis B surface antigen: possible association between low levels of clotting factors and protection against ischaemic heart disease.

T W Meade, Y Stirling, S G Thompson, A Ajdukiewicz, J A Barbara, D M Chalmers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3590098     DOI： 10.1016/0049-3848(87)90336-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  4 in total

1.  Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer.

Authors:  Z Chen; A Keech; R Collins; B Slavin; J Chen; T C Campbell; R Peto
Journal:  BMJ       Date:  1993-04-03

2.  The impact of chronic hepatitis B infection on major adverse cardiovascular events and all-cause mortality in patients with diabetes: a nationwide population-based study from Taiwan.

Authors:  Chin-Sung Kuo; Yung-Tai Chen; Chien-Yi Hsu; Chun-Chin Chang; Ruey-Hsing Chou; Szu-Yuan Li; Shu-Chen Kuo; Po-Hsun Huang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

3.  Chronic hepatitis B virus infection and total and cause-specific mortality: a prospective cohort study of 0.5 million people.

Authors:  Jiahui Si; Canqing Yu; Yu Guo; Zheng Bian; Ruogu Meng; Ling Yang; Yiping Chen; Jianrong Jin; Jingchao Liu; Ziyan Guo; Junshi Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  BMJ Open       Date:  2019-04-09       Impact factor: 2.692

4.  Ischemic Heart Disease in Chronic Hepatitis B: A Danish Nationwide Cohort Study.

Authors:  Frederik Faergemann Lau; Signe Bollerup; Frederik Engsig; Henrik Krarup; Lone Hagens Mygind; Jesper Bach Hansen; Lone Galmstrup Madsen; Peter Thielsen; Ulla Balslev; Lars Nørregaard Nielsen; Toke S Barfod; Mette Rye Clausen; Lise Hobolth; Alex Lund Laursen; Britta Tarp; Birgit T Roege; Jan Gerstoft; Peer Brehm Christensen; Nina Weis
Journal:  Clin Epidemiol       Date:  2022-07-18       Impact factor: 5.814
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.